• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Human umbilical cord derived mesenchymal stem cells in peripheral nerve regeneration

    2020-05-07 12:01:16ChristineBojanicKendrickToBridgetZhangChristopherMakWasimKhan
    World Journal of Stem Cells 2020年4期
    關(guān)鍵詞:所帶科學(xué)合理閱讀課

    Christine Bojanic, Kendrick To, Bridget Zhang, Christopher Mak, Wasim S Khan

    Christine Bojanic, Department of Plastic and Reconstructive Surgery, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, United Kingdom

    Kendrick To, Wasim S Khan, Division of Trauma and Orthopaedic Surgery, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QQ, United Kingdom

    Bridget Zhang, Christopher Mak, School of Clinical Medicine, University of Cambridge,Cambridge CB2 0QQ, United Kingdom

    Abstract

    Key words: Umbilical cord; Mesenchymal stem cells; Transplantation; Peripheral nerve regeneration

    INTRODUCTION

    Peripheral nerve injuries can occur as a result of trauma or disease and can lead to significant morbidity including sensory loss, motor loss and chronic pain[1]. These injuries cause life-long disability in up to 2.8% of all trauma patients[2]. Damage to peripheral nerves most commonly occurs as a result of laceration, compression,ischaemia or traction[1]. As classified by Seddon in 1943, nerve injury can range from focal demyelination termed neurapraxia, to total nerve transection termed neurotmesis[3,4]. The mechanism of recovery post-injury occurs by either branching of collateral axons or by regeneration of the damaged neuron[4,5]. In order for full neuronal recovery to occur, Wallerian degeneration, axonal regeneration and endorgan reinnervation must take place. This is driven by an array of neurotropic factors[4]. However, recovery in function following peripheral nerve injury is hindered by complex pathological mechanisms such as poor nerve regeneration,neuromuscular atrophy, and end-plate degeneration which can lead to suboptimal neuron function[6-9].

    Traditionally, peripheral nerve injury can be managed conservatively or surgically with neurolysis, neural suturing, end-to-side neurorrhaphy and nerve autograft[10-12].Even with optimum surgical repair, most methods will attain partial but not full return of nerve function[10]. Certain peripheral nerve injuries, such as severe brachial plexus or long traction injuries remain inoperable[10]. Autografts have several disadvantages, including donor site morbidity, mismatch in nerve and graft size resulting in poor engraftment, and the potential for development of painful neuromas[11,13,14]. Alternative methods of treating peripheral nerve injuries may be through cell-based regenerative therapies[15].

    Transplantation of mesenchymal stem cells (MSCs), given their regenerative properties and highly proliferative capacity, has been proposed as a promising therapeutic option for peripheral nerve regeneration[16,17]. MSCs are plastic-adherent,undifferentiated, multipotent cells that can be harvested from numerous sites of the body including bone marrow, adipose tissue, dental pulp, amniotic fluid and umbilical cord[17-19]. MSCs from different tissue origins can have distinct cytokine expression profiles, and thus may enable different MSCs to be particularly suited to certain clinical applications[20,21]. Owing to low immunogenicity, MSCs may be transplanted allogenically with minimal consequence[22]. The particular mechanisms through which MSCs aid nerve repair have not yet been fully characterised. MSCs from various sources such as adipose tissue and bone marrow are able to differentiate into Schwann cells[23,24]. While somein vitroexperiments suggest that transplanted MSCs may be stimulated by peripheral nerves to differentiate into Schwann cells[25],alternative findings have instead shown that transplanted MSCs encourage endogenous cells to express regenerative phenotypes[26]. Increasingly, MCSs are believed to mediate their regenerative properties predominantly through paracrine effects[27,28]. Aside from acting through soluble factors[29], MSCs have also demonstrated the ability to secrete extracellular vesicles that contain bioactive components such as miRNA and cytokines[30]. Indeed, native Schwann cells have been shown to facilitate axonal regeneration following injury through secretion of exosomes that decrease GTPase RhoA activity[31]. Similarly, human MSCs may act to achieve the same result through exosomes by upregulation of the PI3 kinase and Akt signalling cascades[32].

    MSCs from umbilical cord are convenient to harvest from post-natal tissue in a non-invasive manner and possess a high capacity to expandex vivo[33]. They express low levels of HLA-DR compared to MSCs from other cell sources and therefore pose low risk of immunogenic complications following allogenic transplantation[34].Through sequential treatment with β-mercaptoethanol and various cytokines,umbilical cord derived MSCs (UCMSCs) can adopt a Schwann-like phenotype[35]. In addition, UCMSCs have been shown to possess greater paracrine effects than those of bone marrow-derived MSCs (BMMSC) and adipose-derived MSCs[17,29], and are able to potentiate axonal regeneration and peripheral nerve functional regeneration through these effects[11,17,29,36]. UCMSCs have been proposed to exert neuroprotective effects through secretion of Brain Derived Neurotrophic Factor (BDNF)[37], angiopoietin-2 and CXCL-16[38,39]. Other studies have suggested that they indirectly promote neurogenesis[40,41]. UCMSCs are also able to indirectly enhance expression of neurotransmitters such as BDNF and neurotrophin-3 (NTF3) which are postulated to aid neuro-regeneration[42,43].

    To date, there have been over 400 clinical trials that explore the use of MSCs in transplantation; UCMSCs follow BMMSCs as the second most commonly used cell source[44]. In this PRISMA systematic review, we analyse the evidence for the use of human UCMSCs in peripheral nerve regeneration by examiningin vivostudies.

    MATERIALS AND METHODS

    A literature search was performed from conception to September 2019 using PubMed,EMBASE and Web of Science. The following search terms were used:((((((((Mesenchymal stem cells) OR mesenchymal stem cell) OR MSC) OR MSCs) OR Mesenchymal stromal cell) OR Mesenchymal cell)) AND (((((Nerve) OR Peripheral nerve) OR Peripheral nerve injury) OR damaged nerve) OR nerve injury)) AND((((((repair) OR regeneration) OR regrowth) OR regenerate) OR renew) OR restore).We adhered to the recommendations as stipulated by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines[45].

    We included case series, case control, cohort studies and randomised controlled trials. We enrolled studies that examined peripheral nerve lesions treated with human UCMSCs inin vivohuman and animal subjects. Studies that only conductedin vitroexperiments were excluded. Studies that investigated central nervous system regeneration using UCMSCs were excluded. All included studies were published in the English language. We excluded all unpublished and retracted literature.

    CB and KT carried out the search independently. RoB2 tool was used by CM and BZ to assess the risk of bias in the studies, all discrepancy in results were resolved by discussion.

    RESULTS

    A total of 210 studies were screened for title, abstract and the inclusion/exclusion criteria were applied (Figure 1). One retracted study was excluded. Fourteen studies were reviewed in full text. The overall bias of studies is shown in Figure 2. The summary of results is shown in Figure 3. All 14 studies were of a case control design(Table 1). Four studies obtained UCMSCs from a third-party source and the remainder were harvested directly from human subjects. Out of the 14 studies, ten involved xenogenic transplantation into sciatic nerve injury specimens that were either crushed or transected. The studies were grouped according to Seddon’s seminal nerve injury classification system, which includes axonotmesis (injury to nerve sheath alone) and neurotmesis (injury to the entire nerve)[3]. A total of 279 subjects were treated with UCMSCs. All studies reported significant improvement in UCMSC treated groups compared with the various different controls and untreated groups.

    The studies did not report any significant complications.

    UCMSCs in peripheral nerve axonotmesis

    Four studies that included a total of 90 treated subjects assessed the use of UCMSCs in peripheral nerve axonotmesis models of sciatic nerve crush injury (Table 1). All four studies harvested UCMSCs from human subjects and transplanted the UCMSCs into murine subjects. The methods of UCMSC delivery to the crush injury varied among studies.

    Studies, by Sunget al[46](2012) and Heiet al[47](2016) examined the effect of direct intralesional UCMSC injections on murine subjects with sciatic nerve crush injuries.Both studies monitored subjects up to 4 wk post-intervention. Sunget al[46](2012)found that expression of brain-derived neurotrophic factor (BDNF) and tyrosine kinase receptor B mRNA increased at 4 wk following UCMSC injection. Functional recovery was measured in terms of the sciatic function index (SFI), which showed a dramatic improvement at 4 wk in UCMSC treated groups compared to untreated groups. Retrograde axonal transport was estimated through fluoro Gold-labelled neuron counts and the UCMSC group was found to have a significantly higher neuron count. It was found that axon density was significantly greater in the UCMSC group. Heiet al[47](2016) transfected UCMSCs with a BDNF-adenovirus vector. The authors found that both UCMSC and BDNF-UCMSC groups had significant improvements in SFI, axon count and axon density at 4 wk after treatment. The BDNF-UCMSC group displayed increased peripheral nerve regeneration compared with UCMSC alone.

    Gartneret al[48,49]conducted two studies published in the same year. In one study,Chitosan type III membrane was used to aid UCMSC infiltration in murine sciatic crush models[48]. The authors evaluated motor and sensory functional recovery up to 12 wk following transplantation with and without Chitosan type III wrapping. Both treatment groups showed improvement in SFI, extensor postural thrust (EPT) and withdrawal reflex latency (WRL). The control group with Chitosan type III membrane alone showed a significant improvement in post-traumatic axonal regrowth compared to the untreated control group. In a separate study, the same group examined the effect of using poly (DL-lactide-e-caprolactone) (PLC) membranes to deliver UCMSCs into sciatic nerve crush injuries[49]. Peripheral nerve regeneration was assessed in terms of SFI, EPT, and WRL at 12 wk. Undifferentiated and differentiated UCMSCs were used in different groups. Both groups showed an increase in myelin sheath thickness compared to control groups. The SFI was severely affected at week-2 postcrush injury in all experimental groups and improved gradually up to week 12 when values were indistinguishable from controls.

    Studies of UCMSCs in peripheral nerve neurotmesis

    Nine of the fourteen studies assessed the use of UCMSCs in peripheral nerve neurotmesis models (Table 2). All nine were case control studies. Five studies had murine subjects, two had rabbit subjects, one had canine subjects, and one had human subjects. Six studies transplanted UCMSCs into a sciatic nerve gap model. Two studies transplanted UCMSCs into tibial nerve and recurrent laryngeal nerve crush models. One study conducted allogenic transplantation in humans. A total of 151 subjects were treated. Methods of MSC delivery and transplantation varied among studies.

    Several groups sought to improve nerve regeneration with UCMSCs combined with longitudinal scaffolds. Zarbakhshet al[11](2015) loaded UCMSCs on a silicone tube and interposed it into a murine sciatic nerve gap model. The authors attempted to compare the histological outcomes of human UCMSCs and rat BMMSCs in regenerating sciatic nerve gap in rats. While the author showed favourable results in nerve regeneration for both UCMSCs and BMMSC, the latter was found to produce superior results at the end point of 12 wk. The BMMSC group showed greater axon number and thicker myelin sheath diameter than the UCMSC group.

    Maet al[17](2019) injected UCMSC-derived extracellular vesicles (EVs) into the tail veins of rats and sutured a silicone rubber tube into the sciatic nerve gaps of 24 rats.The authors found that UCMSC-EVs promoted motor function recovery and regeneration of axons and attenuated muscle atrophy. SFI analysis was used to assess the functional improvements. At 8 wk, UCMSC-EV group had similar SFI values to normal rats.

    總之,幾種教學(xué)方法,只有根據(jù)小學(xué)語文閱讀課的教材實(shí)際,根據(jù)所帶學(xué)生的認(rèn)知特點(diǎn),進(jìn)行有主有次,科學(xué)合理的組織,綜合的運(yùn)用,才能收到卓越的功效。

    Matsuseet al[35](2010) combined UCMSCs and Matrigel into transpermeable tubes and transplanted it into transected murine sciatic nerve tissue specimens. The authors induced UCMSCs into cells with Schwann cell properties by using βmercaptoethanol, all-trans-retinoic acid and various cytokines. Subsequently, Matsuseet al[35]examined the effect of these induced UCMSCs and used two control groups; a positive control of human Schwann cells and a negative control of Matrigel alone. Thegroup assessed SFI values and compared immunoelectron micrographs. They concluded that the treatment group with Schwann Cell-UCMSCs group was equivalent to treatment with Schwann cells based on histological criteria and functional recovery.

    Table 1 Studies of umbilical cord derived mesenchymal stem cells in peripheral nerve axonotmesis and diabetic neuropathy in vivo

    UCMSCs: Umbilical cord derived mesenchymal stem cells; BDNF: Brain-derived neurotrophic factor; SFI: Sciatic function index; PBS: Phosphate buffered saline; PLC: Poly (DL-lactide-ε-caprolactone); WRL: Withdrawal reflex latency; EPT: Extensor postural thrust.

    Cuiet al[14](2018) and Panet al[50](2017) delivered UCMSCs using a collagen conduit. Cuiet al[14](2018) transplanted human UCMSCs into canine sciatic nerve gap models via a longitudinally orientated collagen conduit embedded with UCMSCs.Compound muscle action potential (CMAP) was found to be statistically greater in the UCMSC treated group compared with the collagen conduit only group. Panet al[50](2017) appraised the use of UCMSCs with a heparinised collagen conduits in transected rabbit recurrent laryngeal nerves. The authors assessed the effectiveness of passage-4 UCMSCs loaded on heparinised scaffold that released Nerve growth factor(NGF). Electromyograms at 8 wk revealed that treated lesions recovered normal nerve function. Biological markers of neurogenesis, including calcium-binding protein S100,neurofilament and AChE, were expressed at a greater level following treatment. Xiaoet al[51](2015) undertook a study exploring the effect of UCMSCs in a chitosan conduit interposed into the tibial nerve of a rabbit model. Xiaoet al[51]found that nerve conduction velocity was significantly higher in the treatment group. The myelin sheath thickness and the growth of axis bud were both increased in the UCMSC group. Pereiraet al[52](2014) used PLC as a conduit for UCMSCs in murine sciatic nerve crush models. The group compared differentiated and undifferentiated UCMSCs. They established no difference in the degree of nerve regeneration between UCMSC that were differentiated into neural-glial-like cells and undifferentiated UCMSC groups. Both UCMSC groups showed increased myelin sheath thickness and enhanced recovery in motor and sensory function.

    Two groups sought to investigate the use of UCMSCs embedded on a human amniotic membrane scaffold[5,53]. Liet al[53](2012) found significant improvements in SFI, CMAP and gastrocnemius muscle diameter in UCMSC-loaded scaffolds group compared to cell-free scaffolds. Liet al[6](2013) analysed how UCMSCs loaded on a human amniotic membrane scaffold affected the repair of a transected radial nerve in human subjects. Thirty-two patients with radial nerve injuries from radial shaft fractures were included in the study; twelve patients received neurolysis to remove neural scar tissue, and transplantation of UCMSCs on an amniotic membrane. The remainder 18 patients received neurolysis only. At 12 wk, the electrophysiological function of the UCMSC-treated group had improved electromyography readings. The muscular power, touch sensation and pain sensation were also significantly improved as compared to the neurolysis group.

    Studies of UCMSCs in diabetic neuropathy

    Figure 1 PRlSMA Flow diagram.

    One study explored the role of UCMSCs in femoral nerve neuropathy[54](Table 1). The authors modelled diabetic neuropathy in murine subjects by inducing diabetes with streptozotocin and created a dorsal hind foot ulcer through empyrosis. UCMSCs were delivered intravascularly through the femoral artery in the treatment group. Saline injections were used in the control group. Serum NGF and neurofilament 200 (NF-200) were measured by Enzyme Linked Immunosorbent Assay (ELISA). The results demonstrated that serum NGF and NF-200 increased in the UCMSC treated rats.Additionally, functional studies using electroneurogram showed that femoral nerve conduction was improved in the UCMSC subjects.

    DISCUSSION

    The studies in this review reported compelling positive outcomes for the use of human UCMSC to repair peripheral nerve lesions. None of the studies reported immunogenic nor significant complications. While the source cell utilised was consistent among the studies, there were significant variability in cell treatment and methods of transplantation with variable effectiveness as determined by several different outcome measures. There was also moderate heterogeneity in thein vivomodels used. It is therefore difficult to draw conclusions on the optimal method of cell delivery to nerve lesions. Nevertheless, it does imply that UCMSCs are a useful cell source.

    The process of cell harvest did not vary greatly between the studies. Human umbilical cord and umbilical cord blood are generally considered medical waste and so there are minimal ethical barriers to tissue sampling[55]. This provides a practical advantage for the use of UCMSCs and may explain why it is commonly used in tissue engineering experiments. The biochemical properties of UCMSCs may also be of advantage as studies comparing different source cells for MSCs have found UCMSCs to possess a greater ability to proliferateex vivoand express a higher level of Vascular Endothelial Growth Factor (VEG-F) and Human Growth Factor (HGF) at late passages[56,57]. One study in this review compared UCMSCs to BMMSCs in sciatic nerve regeneration and found BMMSCs to produce superior results. The authors however, evaluated cell architecture on microscopy but did not carry out nerve conduction studies or functional analysis which may better inform clinical relevance[11]. UCMSCs also appear to have a different multilineage differentiation profiles to other MSC, and is able to be induced into neuron-like cellsin vitro, which may favour applications in nerve regeneration[58]. There is some evidence to suggest that characteristics of the donor affect the ability of UCMSCs to differentiate. For example, undifferentiated UCMSCs obtained from patients with pre-eclampsia may produce greater levels of neuronal markers[59]. Therefore, exploration of different patient and gestational characteristics, such as age could help determine optimal source conditions.

    Figure 2 Summary of overall bias.

    There is no set protocol for theex vivoexpansion of UCMSCs in the literature. In our article, UCMSCs were generally transplanted between the third and fifth passage.Indeed, the gene expression profile of UCMSC is known to vary according to the number of passages, with some studies showing that UCMSCs do not express CD105,a defining marker for MSCs, until passage-5[60]. In view of this, it would be meaningful to identify and investigate the expression of important neurogenic markers as a function of stages of passage in future experiments. Some of the studies in this review pre-treated UCMSCs in order to induce them into particular cellular phenotypes prior to transplantation. Pereiraet al[52]and Gartneret al[49]utilised a similar culture protocol and pre-treated UCMSCs with neurogenic media. They observed a neuroglial-like morphology on microscopy and a transcriptomic profile showing upregulation of neuroglial genes including Glial Fibrillary Acidic Protein (GFAP), Growth Associated Protein 43 (GAP43) and Neuronal Specific Nuclear Protein (NeuN). Both studies found differentiated MSCs to be more effective than undifferentiated UCMSCs. Aside from gene expression, it would be important to clarify the exact mechanism through which these differentiated cells act to promote nerve regeneration. The optimal protocol for differentiation is also ill-defined as Matsuseet al[35]used a different set of culture condition to induce UCMSCs into Schwann-like cells and found the latter to be more effective. Furthermore, there is a lack of agreement on the primary mode of action of MSCs in promoting nerve regeneration. It is unclear whether transplanted cells directly replicate and replace cells in the lesion. Some experiments of optic nerve lesions suggest that transplanted MSCs remain local and replicate[61]. Emergingin vitroevidence points towards paracrine effects as the predominant mechanism of action. It appears that pre-treatment of Schwann cells with UCMSC conditioned media increases BDNF and NGF expression which are surrogate measures of neurogenic potential[29]. In our review, Maket al[17]examined the effectiveness of UCMSC-derived exosomes in nerve repair. Through peripheral intravenous injection of UCMSC EVs,they demonstrated that it could act systemically to encourage nerve regeneration at a nerve gap without off-site complications. As the use of EVs in this endeavour gains attention, further studies would be required to establish a dose-response relationship and the best method for delivering EVs to lesions.

    Figure 3 Risk of bias in individual studies.

    It is difficult to determine the best UCMSC implantation method. Our review has captured studies that directly implanted UCMSCs and reported good outcomes.Studies investigating the use of conduits to guide nerve regeneration suggest that this is superior to direct implantation of MSCs alone[14,50]. The use of conduit that elude growth factors such as NGF along with UCMSC implantation appear to confer additional benefit[50]. Additionally, intravenous injection of UCMSC-EVs at a peripheral site also produce positive outcomes[17]. Interestingly, a comparison of local and intravenous BMMSC administration in sciatic nerve injury models suggest that systemic treatment provides a more significant improvement in nerve conduction,whereas local treatment improved neuronal fibre counts[62]. Other experiments have shown that peripherally injected MSCs localise to nerve lesions in murine models of sciatic nerve injury[63]. It could be inferred from these findings that there are differing mechanisms and sites of action for the two methods of implantation, suggesting that a treatment regime including both delivery methods concomitantly may produce the best outcome.

    There are several issues pertaining to translating the findings derived fromin vivoanimal models for therapeutic application in humans. The majority of studies in our review employed a murine surgical sciatic nerve defect model to assess nerve regeneration. The critical nerve gap length, defined as a gap across which regeneration would not occur without nerve grafting or bridging is considered to be greater in humans than murine subjects[64,65]. Therefore, studies assessing murine nerve gaps may overestimate the therapeutic potential of treatments. Furthermore, it may be difficult to scale-up effective concentrations of transplanted UCMSCs to humans. In a study of rat nerve defects treated with tacrolimus, functional recovery tapers off at 9 wk following treatment and becomes indistinguishable from untreated rats at 10 wk[66]. Therefore, at later time points, which are more relevant to clinical presentations of nerve injury, the regenerative biology of murine nerve appears to differ from that of humans. Our interpretation from thein vivoanimal studies in this review is complicated by the use of the sciatic nerve, which possesses a sensory and motor component, and thus renders functional analysis difficult. It is conceivable for sensory loss to mask a post-surgical motor defect on gait analysis, similarly, it may be possible for loss in motor function to cause underestimation of sensory recovery.Owing to the heterogeneity in starting points for different functional measures, a pooled analysis of quantitative outcomes could not be performed in this review.Therefore, clinically relevant and robust quantifiable outcome measures remain a significant barrier to the reliability of animal studies. One study in this review assessed UCMSC transplantation in human radial nerve defects and reported improved motor and sensory function and electrophysiological measures[53]. The group however, delivered the MSCs through a scaffold, and did not compare outcomes with a control group of the scaffold alone.

    According to the results of our risk of bias analysis, 13 of 14 studies had a moderate risk of bias, and one study had a high risk of bias (Figure 1). The reporting of outcome measures contributed to an increased risk of bias in all studies, as most of the studies reported improvement in some but not all outcomes yet concluded that UCMSCs were effective overall. This could be owing to the significant heterogeneity in cell treatment and delivery methods which as the literature suggests, could contribute to different aspects of nerve regeneration.

    Table 2 Studies of umbilical cord derived mesenchymal stem cells in Peripheral Nerve Neurotmesis in vivo

    Li et al[53],2012 Case Control Human Murine 40 amnion tube with UCMSCs 40 amnion tube with saline implant Human umbilical cords obtained from fullterm deliveries Passage 3-4 UCMSCs were cultured and loaded on an amniotic scaffold Xenogenic transplantati on into transected sciatic nerve tissue specimens 20 Significant improvement in SFI and CMAP in UCMSC group compared to control.Gradual improvement in threshold stimulus and maximum stimulus intensity in UCMSC group compared to control Li et al[6],2013 Case Control Human Human 12 neurolysis followed by 10 mL UCMSCs injection of 1.75 × 107 cells 20 neurolysis only Human umbilical cords obtained from fullterm deliveries Passage 2 UCMSCs were loaded on an amniotic membrane scaffold.Both groups received 3 days of oral cephalosporin Allogenic transplantati on into radial nerve injury following radial shaft fracture 12 Significant improvement in muscular strength,touch and pain sensations in UCMSC group compared to control.Improved electrophysiologica l function in UCMSC group as compared to control Matsuse et al[35], 2010 Case Control Human Murine 6 UCMSCs;10 Induced UCMSC 6 negative control; 5 induced UCMSC Wharton’s Jelly extracted from umbilical cords of fullterm caesarean deliveries Passage 3 UCMSCs were induced into Schwannlike cells Xenogenic transplantation into transected sciatic nerve tissue specimens 3 Significant improvement in SFI in all treated as compared to control with the greatest improvement in UCMSC group Xiao et al[51],2015 Case Control Human Rabbit 10 chitosan conduit anastomosis bridge filled with UCMSCs 10 chitosan conduit anastomosis only; 10 untreated Not specified UCMSCs were loaded into a chitosan conduit Xenogenic transplantati on into tibialcommon peroneal nerve endto-side anastomosis 12 Significant improvement in myelin sheath thickness,Schwann cell growth,growth of axis bud and growth velocity of regenerated fibre in UCMSC group compared to controls. No significant difference observed between either control groups

    UCMSCs: Umbilical cord derived mesenchymal stem cells; LOCC: Longitudinally orientated collagen conduit; SFI: Sciatic function index; NGF: Nerve growth factor; PBS: Phosphate buffered saline; HC: Heparinized collagen; PLC: Poly (DL-lactide-ε-caprolactone); EV: Extracellular vesicle.

    In conclusion, while there are homeostatic responses that promote nerve regeneration following injury, the body’s natural capacity is inadequate for the recovery of satisfactory nerve function. The evidence summarised in this systematic review supports the notion that UCMSC transplantation is an effective treatment option for nerve injury. Several barriers must be overcome before these findings can be translated into the clinical setting. Importantly, development of a reliablein vivoanimal model, and a standardised method of assessing nerve regeneration would allow the optimal method of cell transplantation to be determined.

    ARTICLE HIGHLIGHTS

    Research background

    Peripheral nerve injury can be a debilitating condition. Traditional treatment options are often ineffective. There is an urgent need for new treatment modalities. Mesenchymal stem cell (MSC)transplantation holds promise as a cell-based regenerative approach in treating nerve lesions.MSCs can be sourced from various tissues, and this may affect their regenerative capacity. Here,we appraise thein vivoevidence for the use of human umbilical cord-derived MSCs (UCMSCs)in peripheral nerve regeneration.

    Research motivation

    There is contention regarding the optimal cell-source for the harvest of MSCs. Some evidence suggests that MSCs from certain tissue types have superior neurogenic capacity. It is critical that we determine the best cell-source for nerve repair, in order to facilitate an efficient production protocol and maximise clinical benefit.

    Research objectives

    To investigate whether UCMSCs are effective in nerve regeneration inin vivomodels of nerve injury.

    Research methods

    We performed a systematic literature review according to the PRISMA statement. A search was conducted on three databases (PubMed, EMBASE and Web of Science) by two independent investigators from inception to September 2019 for studies examining the use of UCMSCs inin vivomodels of nerve injury. The evidence was appraised using Cochrane’s RoB 2.0 Tool.

    Research results

    A total of 14 studies were included in the review, with a total of 279 subjects. The studies reported that transplantation of human umbilical cord MSCs were effective in regenerating nerve lesions. There were general improvements in histological and functional outcomes. The studies did not report significant complications.

    Research conclusions

    Human umbilical cord-derived MSCs were effective in repairing nerve lesions in both animal and human models of nerve injury. Additional studies are required to correlate histological outcomes with functional improvements, as not all studies assessed both. More human studies are necessary to inform the efficacy in humans. High quality randomized controlled trials would be instructive in this case. Long-term follow up in these types of study will help inform the safety of MSC transplantation.

    Research perspectives

    There is limited evidence examining the use of MSCs derived from other tissues in their capacity to regenerate nerve lesions. Further studies comparing different tissue cell-source directly would be highly informative.In vitrostudies of MSC-biomaterial scaffolds may aid the development of more efficient MSC delivery methods. As the nature of nerve injury can vary significantly, the approach to transplantation, such as dose delivery may need to be catered to the individual lesion. Studies comparing the effect of MSCs on differentin vivomodels could help delineate this.

    猜你喜歡
    所帶科學(xué)合理閱讀課
    基于主題意義的“生本”高中英語閱讀課
    初中英語閱讀課有效詞匯教學(xué)策略
    深山狩獵
    薪酬管理在企業(yè)人才激勵中發(fā)揮的作用
    淺談小學(xué)語文高年級課前預(yù)習(xí)有效指導(dǎo)的研究
    速讀·中旬(2017年3期)2017-05-06 08:18:53
    生活化教學(xué)法在小學(xué)科學(xué)教育中的作用
    “電流和電路”“電壓電阻”易錯題練習(xí)
    合作學(xué)習(xí)在大學(xué)德語閱讀課中的應(yīng)用
    實(shí)現(xiàn)小學(xué)數(shù)學(xué)課堂教學(xué)的高效性
    AneCan戀愛觀大調(diào)查!
    秀·媛尚(2013年6期)2013-09-12 03:17:06
    深爱激情五月婷婷| 中文资源天堂在线| 特大巨黑吊av在线直播| 久久久久网色| 成年女人永久免费观看视频| 26uuu在线亚洲综合色| 国产精品蜜桃在线观看 | 久久午夜亚洲精品久久| 免费搜索国产男女视频| 免费人成视频x8x8入口观看| 一夜夜www| 亚洲精品国产成人久久av| 精华霜和精华液先用哪个| 亚洲精品成人久久久久久| 国产av在哪里看| 成人毛片a级毛片在线播放| 国产伦在线观看视频一区| 国产伦在线观看视频一区| 成人欧美大片| 中文字幕人妻熟人妻熟丝袜美| 麻豆国产av国片精品| 国产精华一区二区三区| 毛片一级片免费看久久久久| 91在线精品国自产拍蜜月| 九色成人免费人妻av| 色吧在线观看| 亚洲欧洲国产日韩| 久久欧美精品欧美久久欧美| 国产乱人视频| 日韩一本色道免费dvd| av天堂中文字幕网| 国内精品一区二区在线观看| 精品少妇黑人巨大在线播放 | 国内精品久久久久精免费| 国产大屁股一区二区在线视频| 久久久国产成人精品二区| 99热这里只有是精品在线观看| 插阴视频在线观看视频| 日韩成人av中文字幕在线观看| 99久久中文字幕三级久久日本| 午夜福利在线在线| 2021天堂中文幕一二区在线观| av在线观看视频网站免费| 日韩欧美 国产精品| 国内精品美女久久久久久| 寂寞人妻少妇视频99o| av福利片在线观看| .国产精品久久| 日韩成人伦理影院| 小蜜桃在线观看免费完整版高清| 久久久精品大字幕| 十八禁国产超污无遮挡网站| 成年av动漫网址| 99热全是精品| 99热6这里只有精品| 美女 人体艺术 gogo| 亚洲欧美日韩高清专用| 美女cb高潮喷水在线观看| 午夜免费激情av| 亚洲国产精品成人久久小说 | 亚洲av二区三区四区| 在线天堂最新版资源| 国产一级毛片七仙女欲春2| 1000部很黄的大片| 22中文网久久字幕| 欧美一区二区精品小视频在线| 亚洲精品亚洲一区二区| 欧美日韩在线观看h| 亚洲欧美日韩无卡精品| 在线观看一区二区三区| 久久久成人免费电影| 美女黄网站色视频| 少妇的逼好多水| 亚洲精品国产成人久久av| 国产高清视频在线观看网站| 免费av毛片视频| 麻豆国产97在线/欧美| 男女边吃奶边做爰视频| 天堂√8在线中文| 免费观看人在逋| 丝袜美腿在线中文| 毛片一级片免费看久久久久| 狠狠狠狠99中文字幕| 18禁在线无遮挡免费观看视频| 国产成人a∨麻豆精品| 国产高清有码在线观看视频| 亚洲aⅴ乱码一区二区在线播放| 日韩av在线大香蕉| 亚洲va在线va天堂va国产| 久久韩国三级中文字幕| 日日干狠狠操夜夜爽| 毛片女人毛片| 老司机影院成人| 午夜爱爱视频在线播放| 乱系列少妇在线播放| a级毛色黄片| 日本黄色片子视频| 日本黄色片子视频| 色尼玛亚洲综合影院| 亚洲在线观看片| 国产午夜精品久久久久久一区二区三区| 国产精品一区二区性色av| 国产爱豆传媒在线观看| 欧美又色又爽又黄视频| 色噜噜av男人的天堂激情| 日韩制服骚丝袜av| 久久精品国产亚洲av香蕉五月| 国产私拍福利视频在线观看| 一边亲一边摸免费视频| av免费在线看不卡| avwww免费| 国产伦精品一区二区三区视频9| 草草在线视频免费看| 99久久中文字幕三级久久日本| 国产真实伦视频高清在线观看| 日本色播在线视频| 大型黄色视频在线免费观看| 一区二区三区高清视频在线| 中文亚洲av片在线观看爽| 亚洲电影在线观看av| 三级男女做爰猛烈吃奶摸视频| 国产精品一区二区在线观看99 | 99在线视频只有这里精品首页| 18禁裸乳无遮挡免费网站照片| 18禁裸乳无遮挡免费网站照片| 少妇裸体淫交视频免费看高清| 国产一区二区激情短视频| 噜噜噜噜噜久久久久久91| 久久久久久久午夜电影| 五月玫瑰六月丁香| 免费不卡的大黄色大毛片视频在线观看 | 蜜桃久久精品国产亚洲av| 国产一级毛片在线| 天天躁日日操中文字幕| 中文精品一卡2卡3卡4更新| 九九久久精品国产亚洲av麻豆| 亚洲美女视频黄频| 免费电影在线观看免费观看| 久久久久久久久大av| 少妇被粗大猛烈的视频| 久久99精品国语久久久| 久久久久久九九精品二区国产| 久久精品91蜜桃| 精品熟女少妇av免费看| 免费人成在线观看视频色| 久久久久久久亚洲中文字幕| 国产色爽女视频免费观看| 国产高清三级在线| 青春草视频在线免费观看| 丝袜喷水一区| 99久国产av精品| 中文字幕免费在线视频6| 老司机福利观看| 亚洲人成网站高清观看| 亚洲性久久影院| 夫妻性生交免费视频一级片| 人体艺术视频欧美日本| 午夜福利高清视频| 91av网一区二区| 亚洲av.av天堂| 99热只有精品国产| 综合色丁香网| 亚洲五月天丁香| 99热全是精品| 非洲黑人性xxxx精品又粗又长| 三级毛片av免费| 夜夜夜夜夜久久久久| 欧美高清性xxxxhd video| 直男gayav资源| 国产精品永久免费网站| 中文在线观看免费www的网站| 中文在线观看免费www的网站| 一级毛片aaaaaa免费看小| 欧美潮喷喷水| 国产日韩欧美在线精品| 国内久久婷婷六月综合欲色啪| av在线老鸭窝| 国内久久婷婷六月综合欲色啪| 亚洲av中文字字幕乱码综合| 91精品一卡2卡3卡4卡| 免费观看精品视频网站| 免费av观看视频| 国产精品乱码一区二三区的特点| 免费观看在线日韩| 日本黄大片高清| 日产精品乱码卡一卡2卡三| 日日啪夜夜撸| ponron亚洲| 日韩一本色道免费dvd| 亚洲成人精品中文字幕电影| 看非洲黑人一级黄片| 久久国产乱子免费精品| 亚洲成人中文字幕在线播放| 国产精品免费一区二区三区在线| 国产一区二区亚洲精品在线观看| 日韩在线高清观看一区二区三区| 99久久成人亚洲精品观看| 中文字幕久久专区| 在线播放无遮挡| 婷婷亚洲欧美| av天堂中文字幕网| 国产精品久久久久久久电影| 色哟哟哟哟哟哟| 亚洲成人中文字幕在线播放| 久久精品影院6| 狠狠狠狠99中文字幕| 国产精华一区二区三区| 最近的中文字幕免费完整| 给我免费播放毛片高清在线观看| 18禁裸乳无遮挡免费网站照片| 在线免费观看不下载黄p国产| 在线免费观看不下载黄p国产| 嘟嘟电影网在线观看| 日本在线视频免费播放| 成人欧美大片| 亚洲色图av天堂| 国产爱豆传媒在线观看| 色噜噜av男人的天堂激情| 爱豆传媒免费全集在线观看| 中国国产av一级| 少妇猛男粗大的猛烈进出视频 | 九九热线精品视视频播放| 亚洲精品影视一区二区三区av| 能在线免费观看的黄片| 午夜激情欧美在线| 国内久久婷婷六月综合欲色啪| 亚洲欧美成人精品一区二区| 特级一级黄色大片| 午夜福利在线观看免费完整高清在 | 国产毛片a区久久久久| 中文字幕av成人在线电影| 久久久久久久久大av| 男女视频在线观看网站免费| 一进一出抽搐动态| 国内久久婷婷六月综合欲色啪| 欧美日韩国产亚洲二区| 全区人妻精品视频| 97人妻精品一区二区三区麻豆| 亚洲自偷自拍三级| 久久这里只有精品中国| 色哟哟·www| 中国国产av一级| 亚洲aⅴ乱码一区二区在线播放| 国产精品嫩草影院av在线观看| 国产美女午夜福利| 内地一区二区视频在线| 成人午夜精彩视频在线观看| 中国美白少妇内射xxxbb| 日韩国内少妇激情av| 一区二区三区高清视频在线| 日韩精品有码人妻一区| 大型黄色视频在线免费观看| 亚洲不卡免费看| 国产精品综合久久久久久久免费| 99久久精品热视频| 日本色播在线视频| 国产毛片a区久久久久| 国产精品国产高清国产av| 91久久精品电影网| 久久亚洲精品不卡| 国产一区二区三区在线臀色熟女| 午夜免费激情av| 91精品国产九色| 99在线视频只有这里精品首页| 欧美成人免费av一区二区三区| 成人欧美大片| 精品熟女少妇av免费看| 日产精品乱码卡一卡2卡三| 亚洲美女视频黄频| 嫩草影院精品99| 一个人观看的视频www高清免费观看| 国产日本99.免费观看| 国产乱人偷精品视频| 亚洲丝袜综合中文字幕| 日日摸夜夜添夜夜添av毛片| 色综合色国产| 悠悠久久av| 久久精品国产清高在天天线| 观看美女的网站| 99久国产av精品国产电影| 国产精品一二三区在线看| 精品人妻一区二区三区麻豆| 日本一本二区三区精品| 国产伦一二天堂av在线观看| av在线观看视频网站免费| 亚洲欧美成人综合另类久久久 | 波多野结衣高清无吗| 国产精品,欧美在线| 18禁在线播放成人免费| 日韩亚洲欧美综合| 别揉我奶头 嗯啊视频| 亚洲图色成人| 色尼玛亚洲综合影院| 国产午夜精品一二区理论片| 色综合色国产| 边亲边吃奶的免费视频| 日韩精品有码人妻一区| 亚洲久久久久久中文字幕| 天堂av国产一区二区熟女人妻| 国产亚洲欧美98| 九九爱精品视频在线观看| 国产在线精品亚洲第一网站| 亚洲最大成人中文| 最好的美女福利视频网| 国产一区二区亚洲精品在线观看| 国产成人影院久久av| 男人狂女人下面高潮的视频| 国产日韩欧美在线精品| 婷婷亚洲欧美| 日日啪夜夜撸| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 中出人妻视频一区二区| 国产精品电影一区二区三区| 12—13女人毛片做爰片一| 久久久久久久久大av| 69av精品久久久久久| 夜夜夜夜夜久久久久| 免费一级毛片在线播放高清视频| 免费无遮挡裸体视频| 日韩精品青青久久久久久| 麻豆国产97在线/欧美| 麻豆成人午夜福利视频| 国产又黄又爽又无遮挡在线| 岛国毛片在线播放| 12—13女人毛片做爰片一| 亚洲美女视频黄频| 69av精品久久久久久| 夜夜夜夜夜久久久久| 精品久久久久久久人妻蜜臀av| 国产极品精品免费视频能看的| 久久婷婷人人爽人人干人人爱| 18禁在线播放成人免费| 最近2019中文字幕mv第一页| 免费黄网站久久成人精品| 黄色欧美视频在线观看| 国产午夜精品一二区理论片| 成年版毛片免费区| 免费观看a级毛片全部| 爱豆传媒免费全集在线观看| 超碰av人人做人人爽久久| 成人性生交大片免费视频hd| 亚洲丝袜综合中文字幕| 欧美不卡视频在线免费观看| 亚洲欧美精品专区久久| 国产成年人精品一区二区| 亚洲精品久久国产高清桃花| 极品教师在线视频| 啦啦啦韩国在线观看视频| 国产免费一级a男人的天堂| 国产精品国产三级国产av玫瑰| 国产黄色小视频在线观看| 一级黄片播放器| 美女被艹到高潮喷水动态| 免费观看在线日韩| 日韩人妻高清精品专区| 久久精品影院6| 日韩一区二区三区影片| 国内久久婷婷六月综合欲色啪| 波野结衣二区三区在线| 久久久午夜欧美精品| 色吧在线观看| 毛片女人毛片| 亚洲欧美日韩高清在线视频| 日本黄大片高清| 久久人人爽人人爽人人片va| 99国产精品一区二区蜜桃av| 晚上一个人看的免费电影| 欧美高清成人免费视频www| 国产爱豆传媒在线观看| 色综合站精品国产| 麻豆成人午夜福利视频| 国产色婷婷99| 三级国产精品欧美在线观看| АⅤ资源中文在线天堂| 国产精品嫩草影院av在线观看| 别揉我奶头 嗯啊视频| 欧美不卡视频在线免费观看| 3wmmmm亚洲av在线观看| 亚洲aⅴ乱码一区二区在线播放| 国产淫片久久久久久久久| 亚洲欧美日韩高清在线视频| 22中文网久久字幕| 亚洲自偷自拍三级| 好男人视频免费观看在线| 又爽又黄无遮挡网站| 日韩国内少妇激情av| 亚洲欧洲国产日韩| 一级毛片久久久久久久久女| 午夜爱爱视频在线播放| 午夜视频国产福利| 久久人人精品亚洲av| av卡一久久| 国产精品永久免费网站| 久久精品91蜜桃| 国产精品日韩av在线免费观看| 成年免费大片在线观看| 欧美高清成人免费视频www| 国产一区二区三区av在线 | 啦啦啦观看免费观看视频高清| 久久99蜜桃精品久久| 午夜亚洲福利在线播放| 男女做爰动态图高潮gif福利片| 亚洲精品自拍成人| 99热网站在线观看| 美女内射精品一级片tv| 午夜福利成人在线免费观看| 一个人看的www免费观看视频| 人人妻人人澡欧美一区二区| 欧美性感艳星| 亚洲第一电影网av| 神马国产精品三级电影在线观看| АⅤ资源中文在线天堂| 国产老妇伦熟女老妇高清| 高清毛片免费看| 伦理电影大哥的女人| 久久人人精品亚洲av| 欧美成人a在线观看| 色尼玛亚洲综合影院| 小说图片视频综合网站| 亚洲av.av天堂| 一区二区三区免费毛片| 老师上课跳d突然被开到最大视频| 在线天堂最新版资源| 成人国产麻豆网| 亚洲av第一区精品v没综合| 女的被弄到高潮叫床怎么办| 国内精品一区二区在线观看| 国产精品,欧美在线| 久99久视频精品免费| 国产激情偷乱视频一区二区| 国产三级中文精品| or卡值多少钱| 精品日产1卡2卡| www.av在线官网国产| 少妇人妻一区二区三区视频| 男女视频在线观看网站免费| 观看免费一级毛片| 国产高潮美女av| 最近视频中文字幕2019在线8| 欧美3d第一页| 日韩一区二区视频免费看| 亚洲欧美精品自产自拍| 亚洲精品色激情综合| 一本一本综合久久| 日韩一区二区视频免费看| 一级黄色大片毛片| 菩萨蛮人人尽说江南好唐韦庄 | 精品一区二区三区视频在线| 国产色爽女视频免费观看| 99久久久亚洲精品蜜臀av| 欧美一区二区国产精品久久精品| 国产69精品久久久久777片| 大香蕉久久网| 亚洲欧洲国产日韩| 天天躁日日操中文字幕| 国产av不卡久久| 一个人观看的视频www高清免费观看| 午夜久久久久精精品| 亚洲激情五月婷婷啪啪| 久久久久久久午夜电影| 国产单亲对白刺激| av天堂中文字幕网| 一边亲一边摸免费视频| 日韩 亚洲 欧美在线| 久久久久免费精品人妻一区二区| 看非洲黑人一级黄片| 亚洲aⅴ乱码一区二区在线播放| 久久精品国产亚洲av天美| 亚洲经典国产精华液单| 成人国产麻豆网| 日韩欧美精品免费久久| 国产在视频线在精品| ponron亚洲| 一本久久精品| 中文字幕久久专区| 亚洲乱码一区二区免费版| 国模一区二区三区四区视频| 免费一级毛片在线播放高清视频| 久久国产乱子免费精品| 亚洲欧美日韩卡通动漫| 又黄又爽又刺激的免费视频.| 色哟哟哟哟哟哟| 69人妻影院| 特大巨黑吊av在线直播| 亚洲精品亚洲一区二区| 久久6这里有精品| 青春草视频在线免费观看| 亚洲av中文av极速乱| 一夜夜www| 亚洲三级黄色毛片| 男人舔奶头视频| 91久久精品国产一区二区成人| av在线老鸭窝| 大型黄色视频在线免费观看| 精品久久久久久久末码| 欧美潮喷喷水| 欧美又色又爽又黄视频| 夜夜爽天天搞| 日韩一区二区视频免费看| 亚洲精品亚洲一区二区| 久久6这里有精品| 可以在线观看毛片的网站| 村上凉子中文字幕在线| 午夜福利视频1000在线观看| 午夜免费男女啪啪视频观看| 亚洲乱码一区二区免费版| 国产精华一区二区三区| 伊人久久精品亚洲午夜| 床上黄色一级片| 夜夜夜夜夜久久久久| 波野结衣二区三区在线| 亚洲自偷自拍三级| 久久99热6这里只有精品| 成人高潮视频无遮挡免费网站| 国产精品人妻久久久影院| 非洲黑人性xxxx精品又粗又长| 亚洲在久久综合| 久久精品综合一区二区三区| 中文字幕制服av| 色哟哟哟哟哟哟| 卡戴珊不雅视频在线播放| 又爽又黄a免费视频| 人人妻人人澡欧美一区二区| 日韩欧美精品免费久久| 免费观看精品视频网站| 国产精品无大码| 在线观看午夜福利视频| 在线播放无遮挡| av又黄又爽大尺度在线免费看 | 网址你懂的国产日韩在线| 亚洲精品日韩av片在线观看| 亚洲av第一区精品v没综合| 联通29元200g的流量卡| 日韩制服骚丝袜av| 亚洲成人久久爱视频| 大香蕉久久网| 又粗又硬又长又爽又黄的视频 | 欧美成人精品欧美一级黄| 波野结衣二区三区在线| 国产一区亚洲一区在线观看| 精品无人区乱码1区二区| 在线a可以看的网站| or卡值多少钱| 午夜精品一区二区三区免费看| eeuss影院久久| 非洲黑人性xxxx精品又粗又长| 亚洲最大成人中文| 亚洲精品粉嫩美女一区| 久久久久久久亚洲中文字幕| 日产精品乱码卡一卡2卡三| 99国产精品一区二区蜜桃av| 美女被艹到高潮喷水动态| 男女做爰动态图高潮gif福利片| 美女 人体艺术 gogo| 欧美日韩一区二区视频在线观看视频在线 | 欧美成人a在线观看| kizo精华| 免费观看a级毛片全部| 插阴视频在线观看视频| 日韩在线高清观看一区二区三区| 久久精品国产亚洲av香蕉五月| 99热6这里只有精品| 精品一区二区三区人妻视频| 毛片一级片免费看久久久久| 免费观看精品视频网站| 国产蜜桃级精品一区二区三区| 乱系列少妇在线播放| 少妇熟女aⅴ在线视频| 国产一区二区在线av高清观看| 日本三级黄在线观看| 欧美日本亚洲视频在线播放| 成年免费大片在线观看| 久久久久久九九精品二区国产| 天天躁日日操中文字幕| 欧美激情国产日韩精品一区| 国产私拍福利视频在线观看| 精品久久久久久成人av| 人人妻人人澡欧美一区二区| 在现免费观看毛片| 伊人久久精品亚洲午夜| 97在线视频观看| 久久久久久久亚洲中文字幕| 久久99精品国语久久久| 一本久久精品| 在线观看免费视频日本深夜| 春色校园在线视频观看| 在线a可以看的网站| 能在线免费看毛片的网站| 99久久九九国产精品国产免费| 免费人成视频x8x8入口观看| 国产极品精品免费视频能看的| 国产真实乱freesex| 欧美+亚洲+日韩+国产| 99热这里只有是精品在线观看| 国产精品综合久久久久久久免费| 国产美女午夜福利| 久久99精品国语久久久| 99热这里只有是精品在线观看| 亚洲人成网站在线播放欧美日韩| 一本久久中文字幕| 麻豆久久精品国产亚洲av| 美女 人体艺术 gogo| 又粗又爽又猛毛片免费看| 日本撒尿小便嘘嘘汇集6| 成人三级黄色视频| 亚洲精品乱码久久久v下载方式| 18禁黄网站禁片免费观看直播| 干丝袜人妻中文字幕| 边亲边吃奶的免费视频| 少妇猛男粗大的猛烈进出视频 | 丰满的人妻完整版| 亚洲欧美清纯卡通| 不卡视频在线观看欧美| 欧美性猛交黑人性爽| 免费观看精品视频网站|